[Critical review of anti-influenza drugs].
Claas
E C
EC
Kroes
A C
AC
D000998:Antiviral Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009980:Influenza A virus / Q000187:drug effects / Q000472:pathogenicity*; D009981:Influenza B virus / Q000187:drug effects / Q000472:pathogenicity*; D007251:Influenza, Human / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D009426:Netherlands / Q000453:epidemiology; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D013997:Time Factors; D014611:Vaccination / Q000191:economics
D000998:Antiviral Agents; D009439:Neuraminidase